MOLTENI, LAURA
 Distribuzione geografica
Continente #
AS - Asia 5.214
NA - Nord America 5.180
EU - Europa 2.979
SA - Sud America 459
AF - Africa 76
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 13.921
Nazione #
US - Stati Uniti d'America 4.979
VN - Vietnam 2.431
IT - Italia 1.071
SG - Singapore 1.032
CN - Cina 690
DE - Germania 444
HK - Hong Kong 420
BR - Brasile 344
RU - Federazione Russa 316
IE - Irlanda 170
GB - Regno Unito 161
SE - Svezia 158
CA - Canada 143
IN - India 126
FR - Francia 123
AT - Austria 91
KR - Corea 90
ID - Indonesia 81
FI - Finlandia 78
ES - Italia 67
BD - Bangladesh 65
UA - Ucraina 63
PL - Polonia 53
TR - Turchia 43
AR - Argentina 40
BE - Belgio 34
JP - Giappone 34
DK - Danimarca 33
MX - Messico 31
CH - Svizzera 30
IQ - Iraq 30
TW - Taiwan 30
NL - Olanda 28
PK - Pakistan 26
ZA - Sudafrica 24
PH - Filippine 19
EC - Ecuador 18
CO - Colombia 17
MY - Malesia 11
SA - Arabia Saudita 11
UZ - Uzbekistan 11
KE - Kenya 10
PY - Paraguay 10
AU - Australia 9
CL - Cile 9
CZ - Repubblica Ceca 9
LT - Lituania 9
VE - Venezuela 9
HN - Honduras 8
IR - Iran 8
MA - Marocco 8
RO - Romania 8
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
JO - Giordania 6
NP - Nepal 6
PT - Portogallo 6
BG - Bulgaria 5
EG - Egitto 5
OM - Oman 5
PE - Perù 5
PS - Palestinian Territory 5
TH - Thailandia 5
AZ - Azerbaigian 4
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
NG - Nigeria 4
TN - Tunisia 4
AL - Albania 3
EE - Estonia 3
HR - Croazia 3
LB - Libano 3
NZ - Nuova Zelanda 3
RS - Serbia 3
SN - Senegal 3
UY - Uruguay 3
ET - Etiopia 2
GE - Georgia 2
HU - Ungheria 2
LY - Libia 2
MN - Mongolia 2
PA - Panama 2
AO - Angola 1
BH - Bahrain 1
BJ - Benin 1
BY - Bielorussia 1
CD - Congo 1
CM - Camerun 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
Totale 13.907
Città #
Ann Arbor 1.022
Ho Chi Minh City 756
Hanoi 628
Singapore 623
Ashburn 436
Hong Kong 406
San Jose 350
Milan 348
Frankfurt am Main 323
Chandler 254
Wilmington 210
Dallas 205
Dublin 164
Woodbridge 161
Beijing 147
Fairfield 144
New York 131
Los Angeles 124
Dearborn 83
Santa Clara 82
Vienna 82
Toronto 81
Chicago 80
Haiphong 80
Houston 79
Da Nang 75
Seattle 74
Hefei 71
Jakarta 68
Biên Hòa 63
Princeton 60
Rome 59
Seoul 58
Council Bluffs 56
Cambridge 54
The Dalles 53
Ha Long 48
London 46
Quận Bình Thạnh 46
Helsinki 45
Jacksonville 45
Buffalo 44
Lauterbourg 43
São Paulo 43
Shanghai 37
Hải Dương 34
Munich 34
Thái Nguyên 34
Can Tho 33
Nanjing 33
Boardman 31
Quận Một 31
Columbus 30
Kent 30
Moscow 28
Ninh Bình 28
Tokyo 28
Warsaw 28
Pune 27
Brussels 26
Bắc Ninh 26
Granada 26
Quận Phú Nhuận 26
Bắc Giang 23
Guangzhou 23
Orem 23
Nuremberg 22
Vũng Tàu 22
Denver 21
Phủ Lý 21
Fremont 20
Monza 18
Rio de Janeiro 18
Baghdad 17
Lawrence 17
Kaohsiung 16
Stockholm 16
Turin 16
Turku 16
Vinh 16
Zurich 16
Boston 15
Phoenix 15
Poplar 15
Altamura 14
Brooklyn 14
Ankara 13
Nam Định 13
Quận Bảy 13
Quận Sáu 13
Romola 13
San Diego 13
San Francisco 13
Thu Dau Mot 13
Điện Bàn 13
Andover 12
Montreal 12
Lấp Vò 11
Manchester 11
Quảng Ninh 11
Totale 9.208
Nome #
Histone Deacetylase 6 Inhibitors: Mitigators Of Chemotherapy Induced Peripheral Neuropathy Via The NMNAT2/SARM1 Pathway Modulation 1.130
Evaluation of Histone Deacetylase 6 inhibitors as possible neuroprotectors against Paclitaxel-induced peripheral neurotoxicity 758
Study of the tissue distribution of TLQP-21 in mice using [18F]JMV5763, a radiolabeled Analog prepared via [18F]aluminum fluoride chelation chemistry 532
Intranasal delivery of mesenchymal stem cell-derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease 514
Palmitoylethanolamide modulation of microglia activation: Characterization of mechanisms of action and implication for its neuroprotective effects 514
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 502
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 459
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 448
Growth hormone secretagogues and the regulation of calcium signaling in muscle 447
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 394
JMV5656, a short synthetic derivative of TLQP-21, alleviates acid-induced lung injury and fibrosis in mice 368
PHARMACOLOGICAL CHARACTERIZATION OF THE INTRACELLULAR SIGNALLING PATHWAY ACTIVATED BY TLQP-21 357
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 355
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 339
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 331
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 322
Cannabinoid Receptor 2 (CB2R) as potential target for the pharmacological treatment of neurodegenerative diseases 308
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 306
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 305
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 303
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 297
Parma consensus statement on metabolic disruptors 296
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 289
The Role of NMNAT2/SARM1 in Neuropathy Development 282
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
TLQP-21 modulate inflammation and fibrosis in a model of ards 273
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 272
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 255
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 244
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 228
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 213
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 203
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 199
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 194
Transgenic zebrafish embryos to evaluate the in vivo effects of different liposome-paclitaxel nanocarrier system 193
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 193
SARM1 modulation by HDAC6 inhibition as a neuroprotective strategy in chemotherapy-induced peripheral neuropathy 171
Effects of hexarelin on the modulation of apoptosis pathway induced by hydrogen peroxide 169
Evaluation of the neuroprotective effects of growth hormone secretagogues and glycosaminoglycans in an in vitro model of glutamate toxicity 151
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 144
Neuroprotectiveeffectsof hexarelinin an in vitro model of ALS 137
Hexarelin reduces H2O2-induced oxidative stress in Neuro2A cell line 135
Targeted Paclitaxel Delivery Via Metalloproteinase-Sensitive Liposomes To Prevent Peripheral Neurotoxicity: A Proof Of Concept 127
Correction to: Parma consensus statement on metabolic disruptors (Environmental Health: A Global Access Science Source (2015) 14:1 (54) DOI: 10.1186/s12940-015-0042-7) 125
REDUCING PACLITAXEL-INDUCED PERIPHERAL NEUROTOXICITY VIA LIPOSOMAL DRUG TARGETING 125
Role of nutrition in degenerative disease 107
Totale 14.296
Categoria #
all - tutte 38.101
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.101


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022656 91 71 56 52 37 44 22 21 24 58 58 122
2022/20231.122 130 252 140 116 56 172 21 79 75 17 33 31
2023/2024726 26 39 41 53 76 202 121 28 42 13 14 71
2024/20251.993 96 132 118 120 156 120 165 62 131 250 177 466
2025/20267.266 2.138 836 485 574 517 268 767 245 422 473 249 292
2026/202756 56 0 0 0 0 0 0 0 0 0 0 0
Totale 14.296